✨ Your Portfolio is fetched and updated from zerodha.

Pharma Sector

Index
  • 1m
  • 6m
  • ytd
  • 1y
  • 3y
  • 5y
  • max
Constituents (238 Companies)
Company Name
PE
Market Cap (Cr.)
M.Cap (Cr.)
37.26
3,86,497
70.16
1,61,787
23.34
1,25,870
59.74
1,19,591
19.25
1,09,380
56.03
1,06,044
22.78
1,04,145
25.33
93,694
28.82
65,847
45.31
65,800
18.70
63,421
77.77
58,615
94.97
48,322
125
48,144
103
46,656
48.82
46,392
147
37,859
43.24
33,302
42.67
33,223
34.29
31,889
278
27,323
38.46
26,353
34.64
25,783
-
25,164
29.07
23,508
58.52
22,652
122
22,547
-
21,073
118
20,787
56.29
20,131
31.60
19,057
108
18,462
38.74
17,827
30.20
17,066
47.62
16,957
9.00
15,275
166
13,909
31.61
13,765
27.32
13,102
34.58
12,399
60.70
12,139
63.22
11,953
28.03
11,583
23.17
11,484
35.04
10,533
56.39
10,056
31.01
8,262
22.29
8,092
72.72
8,080
22.79
7,980
28.20
7,589
21.88
7,471
29.34
5,226
-
5,214
37.98
4,930
158
4,705
24.68
4,661
-
4,502
40.14
4,183
93.26
4,159
21.58
3,944
28.24
3,866
59.05
3,653
42.19
3,595
27.13
3,550
48.97
3,458
32.18
3,379
52.17
3,303
132
3,255
53.95
3,160
31.56
2,922
-
2,806
8.75
2,771
36.53
2,672
231
2,656
40.30
2,197
32.41
2,112
62.81
1,995
43.27
1,836
46.58
1,751
29.49
1,698
26.41
1,666
27.12
1,649
15.01
1,601
29.25
1,377
127
1,290
-
1,147
12.84
1,108
55.08
1,105
9.80
1,024
23.16
1,005
-
934
19.08
880
41.99
877
3.76
870
24.58
858
19.49
838
38.26
756
33.18
726
44.78
715
37.80
714
22.66
635
18.95
626
10.98
590
25.14
589
-
585
28.26
580
52.58
552
24.56
545
15.12
491
-
469
48.41
460
-
459
72.70
457
32.28
431
65.90
408
-
382
45.31
368
39.03
367
21.19
366
38.22
366
46.86
352
27.92
328
61.48
323
31.21
322
18.20
306
69.76
298
35.93
292
33.98
281
-
259
-
255
25.73
253
9.89
240
18.44
236
24.71
236
116
232
49.41
205
-
202
7.57
198
-
194
10.56
189
14.00
189
34.38
184
660
171
-
170
17.01
164
47.88
162
36.67
161
14.70
159
394
157
11.51
156
218
153
11.99
145
9.42
143
19.79
142
16.05
136
16.93
136
11.54
124
32.95
123
-
119
12.16
117
15.67
104
27.06
102
17.52
100
904
100
20.68
100
-
96
29.74
93
17.93
89
20.17
87
9.35
83
9.60
81
71.66
75
10.63
72
25.30
71
-
70
163
70
17.18
65
15.19
64
-
61
7.18
52
45.26
50
30.47
47
45.31
47
-
47
10.82
45
13.61
45
21.49
44
-
44
10.63
44
95.31
42
12.77
42
41.02
41
54.88
40
-
39
16.16
38
14.09
37
-
37
73.22
37
161
36
12.68
35
38.74
33
55.73
33
-
32
-
31
30.37
29
12.54
26
-
26
145
26
84.34
25
-
23
22.79
23
-
19
18.28
19
-
18
-
17
-
17
40.47
16
-
12
52.84
12
-
11
113
11
22.39
11
40.30
10
-
10
-
10
-
9
966
9
110
9
281
8
-
6
87.72
5
-
5
-
5
-
4
41.81
3
-
2
-
-
Showing 5 238 of 238 Show More
Market Share

    Select a Metric
    • Fermentation Based API Products - Market Share (%)
    • Gastrointestinal (Nurokind-LC) - Market Share (%)
    • Depression (Placida) - Market Share (%)
    • Anti-Hypertensives (Amolkind-AT) Market Share (%)
    • Anti Fungal Antibiotics (Terbinaforce) - Market Share (%)
    • Birth Control (Unwanted-72) - Market Share (%)
    • Anti - Diabetes - Market Share (%)
    • Anti-Infectives - Market Share (%)
    • Cardiovascular - Market Share (%)
    • Gastro-Intestinal - Market Share (%)
    • Pharmaceutical Sector - Market Share (%)
    • Sex Stimulants - Market Share (%)
    • Vaccines - Market Share (%)
    • Vitamin & Dietary Supplements - Market Share (%)
    Operational Metrics

    Select a Metric
    • Pharma spend as a % of GDP - India (%)
    • Pharma spend as a % of GDP - Korea (%)
    • Pharma spend as a % of GDP - USA (%)
    • Domestic Pharma - Monthly Sales (Crs)
    • Domestic Pharma Price Growth (%)
    • Domestic Pharma Volume Growth (%)
    • Total ANDA's Approved by USFDA

      Select a Metric
      • Fermentation Capacity (KL)
      • No Of Pharmacies (.)
      • Number of ANDA's Approved By USFDA (.)
      • Number of ANDA's Filed in USA (.)
      • Manufacturing Capacity - Metformin (MTPA)
      • No of Pharmacy Outlets - Kolkata (.)
      • Quarterly Sales Volume - Injectables (Nos)
      • Quarterly Sales Volume - Nutraceuticals (Nos)
      • Quarterly Sales Volume - Orals (Nos)
      • Realization / Tonne - Piperazine (Rs/MT)
      • Manufacturing Capacity - Pyridin-3-One (MTPA)
      • Realization / Tonne - Pyridin-3-One (Rs/MT)
      • Domestic Sales Growth - YoY (%)
      • Number of ANDA's Approved (.)
      • Number of ANDA's Filed in Europe
      • Number of ANDA's Approved in Europe
      • Canada DMF fillings (.)
      • US DMF Filings (.)
      • Australia DMF fillings (.)
      • US DMF Approval (.)
      • Europe DMF Filings (.)
      • DMF Filingsby API (.)
      • Total reactor capacity (kL)
      • Global DMFs filed (.)
      • APIs Production Capacity (MTPA)
      • Japan DMF Filings (.)
      • Realization - Tetralone (Rs/Tonne)
      • Manufacturing Capacity - Omeprazole (MTPA)
      • Capacity Utilization - Esomeprazole (%)
      • Realization - Pantaprazole Sodium (Rs/Tonne)
      • Capacity Utilization - Benzimidazole (%)
      • Capacity Utilization - Omeprazole (%)
      • Manufacturing Capacity - Benzimidazole (MTPA)
      • Realization - Chloro Compound (Rs/Tonne)
      • Manufacturing Capacity - Pantaprazole (MTPA)
      • Realization - Op. Sulphide (Rs/Tonne)
      • Realization - Esomeprazole Magnesium (Rs/Tonne)
      • Capacity Utilization - Chloro Compound (%)
      • Capacity Utilization - Pantaprazole (%)
      • Realization - Benzimidazole (Rs/Tonne)
      • Realization - Omeprazole Powder (Rs/Tonne)
      • Manufacturing Capacity - Esomeprazole (MTPA)
      • Manufacturing Capacity - Chloro Compound (MTPA)
      • Realization - Ammonium Sulphate (Rs/Tonne)
      • Manufacturing Capacity - Ibuprofen (MTPA)
      • Capacity Utilization - Pharmaceuticals (%)
      • Number of ANDA's Filed in Canada
      • Number of ANDA's Approved by Canada
      • Number of ANDA's Filed in Australia
      • Number of ANDA's Approved by Australia
      • Number of ANDA's Filed in South Africa
      • Number of ANDA's Approved by South Africa
      • Number of ANDA's Filed in Latam
      • Number of ANDA's Approved by Latam
      • Manufacturing Capacity - Piperazine (MTPA)
      • Manufacturing Capacity - Paracetamol (MTPA)
      • No of Pharmacy Outlets - Hyderabad (.)
      • No of Pharmacy Outlets - Bangalore (.)
      • No of Pharmacy Outlets - Chennai (.)
      Segments

      Select a Metric
      • Therapeutic wise Break-Up - Domestic Pharma (Crs)
      • Dermatology (Crs)
      • Cardiovascular (Crs)
      • Blood Related (Crs)
      • Antineo Plastic (Crs)
      • Anti-Malarial (Crs)
      • Anti - Infectives (Crs)
      • Vaccines (Crs)
      • Stomatological (Crs)
      • Sex Stimulants (Crs)
      • Respiratory (Crs)
      • Pain (Crs)
      • Others (Crs)
      • Ophthalmology (Crs)
      • Neurological (Crs)
      • Gynecology (Crs)
      • Gastro-Intestinal (Crs)
      • Endocrinology (Crs)
      • Urology (Crs)
      • Vitamin & Dietary Supplements (Crs)
      • Anti - Diabetes (Crs)
      • Indian vs MNC - Domestic Share (Crs)
      • Indian (Crs)
      • MNC (Crs)
      Export Import Data

      • 1y
      • 2y
      • 3y
      • 5y
      • 10y
        Select a Metric
        • Pharmaceutical Products (Kgs)
        Ideas Dashboard
        Results
        Timeline
        Watchlist
        Portfolio
        Alerts
        Stock Screener
        Market
        Raw Material